Type of fluid in severe sepsis and septic shock

Minerva Anestesiologica

Volumn 77, Issue 12, 2011, Pages 1190-1196

  Vincent, J L ^a   Gottin, L ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Albumins; Colloids; Crystalloid solutions

Indexed keywords

DEXTRAN; FUROSEMIDE; GELATIN; HETASTARCH; HUMAN ALBUMIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANAPHYLAXIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLLOID; CRITICALLY ILL PATIENT; CRYSTALLOID; DISEASE SEVERITY; DRUG COST; DRUG HYPERSENSITIVITY; ELECTROLYTE BALANCE; ELECTROLYTE DISTURBANCE; FLUID RESUSCITATION; HEMOSTASIS; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPOALBUMINEMIA; HYPONATREMIA; HYPOPROTEINEMIA; HYPOVOLEMIA; KIDNEY DISEASE; KIDNEY FAILURE; MORTALITY; ONCOTIC PRESSURE; PROGNOSIS; PRURITUS; RENAL REPLACEMENT THERAPY; SEPSIS; SEPTIC SHOCK; SIDE EFFECT;

ALBUMINS; COLLOIDS; CRITICAL ILLNESS; FLUID THERAPY; GELATIN; HETASTARCH; HUMANS; ISOTONIC SOLUTIONS; PLASMA SUBSTITUTES; SEPSIS; SHOCK, SEPTIC; SODIUM CHLORIDE;

EID: 82955194690     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. prough DS, Bidani A. Hyperchloremic metabolic acidosis is a predictable consequence of intraoperative infusion of 0.9% saline. Anesthesiology 1999;90:1247-9.
2. Wilkes NJ, Woolf R, Mutch M, Mallett SV, peachey T, Stephens R et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001;93:811-6.
3. Mythen MG, Hamilton MA. Hyperchloremic acidosis: Is it clinically relevant? Transfusion Alternatives in Transfusion Medicine 2001;3:15-9.
4. Libert N, De Rudnicki S, Cirodde A, Tepenier C, Mion G. Is there any place for hypertonic saline for fuid resuscitation in septic shock. Ann Fr Anesth Reanim 2010;29:25-35.
5. Oliveira RP, Velasco I, Soriano FG, Friedman G. Clinical Review: Hypertonic saline esuscitation in sepsis. Crit Care 2002;6:418-23.
6. Hartmann AF. Theory and practice of parenteral fuid administration. JAMA 1934;103:1349-54.
7. Tommasino C. Fluids and the neurosurgical patient. An-esthesiol Clin North America 2002;20:329-46, vi.
8. Saidenberg E, Tinmouth A. Ringers lactate and red blood cells: is there sufcient evidence to recommend for routine use? Can J Anaesth 2009;56:343-7.
9. Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med 2006;34:2536-40.
10. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hy-poalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003;237:319-34.
11. Lang JD Jr, Figueroa M, Chumley p, Aslan M, Hurt J, Tarpey MM et al. Albumin and hydroxyethyl starch modulate oxidative infammatory injury to vascular endothelium. Anesthesiology 2004;100:51-8.
12. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gut-teridge JM, Evans TW Albumin inf uences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004;32:755-9.
13. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998;317:235-40.
14. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fuid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56.
15. Finfer S, Bellomo R, McEvoy S, Lo Sk, Myburgh J, Neal B et al. Efect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fuid evaluation (SAFE) study. BMJ 2006;333:1044.
16. Davidson IJ. Renal impact of fuid management with colloids: a comparative review. Eur J Anaesthesiol 2006;23:721-38.
17. Ljungstrom KG. Pretreatment with dextran 1 makes dex-tran 40 therapy safer. J Vasc Surg 2006;43:1070-2.
18. Niemi TT, Miyashita R, Yamakage M. Colloid solutions: a clinical update. J Anesth 2010;24:913-25.
19. Bork k. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005;152:3-12.
20. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F et al. Efects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-6.
21. Sakr Y, payen D, Reinhart k, Sipmann FS, Zavala E, Be-wley J et al. Efects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007;98:216-24.
22. Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D et al. Efects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fuid therapy on renal function in surgical ICU patients. Intensive Care Med 2009;35:1539-47.
23. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
24. Wiedermann CJ. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fuid management in sepsis. BMC Emerg Med 2008;8:1.
25. Dart AB, Mutter TC, Ruth CA, Taback S. Hydroxyethyl starch (HES) versus other fuid therapies: efpects on kidney function. Cochrane Database Syst Rev 2010:CD007594.
26. Zarychanski R, Turgeon AF, Fergusson DA, Cook DJ, He-bert P, Bagshaw SM et al. Renal outcomes and mortality fol-loiwng hydroxyethyl starch resuscitation of critically ill patients: Systematic review and meta-analysis of randomized trials. Open Medicine 2009;3:E196-E209.
27. Westphal M, James MF, kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products--diferent efects. Anesthesiology 2009; 111:187-202.
28. Hartog CS, Bauer M, Reinhart K. Review article: the effcacy and safety of colloid resuscitation in the critically ill. AnesthAnalg 2011;112:156-64.
29. Groeneveld AB, Navickis RJ, Wilkes MM. Update on the comparative safety of colloids: A systematic review of clinical studies. Ann Surg 2011 [In press].
30. Rackow EC, Falk JL, Fein IA, Siegel JS, packman MI, Haupt MT et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory ef ects of albumin, het-astarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983;11:839-50.
31. Trof RJ, Sukul SP, Twisk JW, Girbes AR, Groeneveld AB. Greater cardiac response of colloid than saline fuid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med 2010;36:697-701.
32. Camacho MT, Totapally BR, Torbati D, Wolfsdorf J. pulmonary and extrapulmonary efects of increased colloid osmotic pressure during endotoxemia in rats. Chest 2001;120:1655-62.
33. van der Heijden M, Verheij J, Nieuw Amerongen GP, Groeneveld AB. Crystalloid or colloid fuid loading and pulmonary permeability, edema, and injury in septic and nonsep-tic critically ill patients with hypovolemia. Crit Care Med 2009;37:1275-81.
34. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005;33:1681-7.
35. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008;34:17-60.
36. Su F, Wang Z, Cai Y, Rogiers P, Vincent JL. Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer's lactate-does it really make a diference? Shock 2007;27:520-6.
37. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, knoblich B et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
38. Ospina-Tascon G, Neves AP, Occhipinti G, Donadello K, Buchele G, Simion D et al. Ef ects of fuids on microvascular perfusion in patients with severe sepsis. Intensive Care Med 2010;36:949-55.
39. Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004;32:S451-S4.
40. Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med 2006;34:1333-7.